Chronic pelvic pain syndrome
Conditions
Interventions
CPPS patients take Ryutanshakanto with 2.5 g per time before each meal. Administration will be continued for 84 days basically.
Sponsors
Yokohama City University
Yokohama City University Mecidal Center Kinugasa Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who has pelvic pain continuously for more than 3 months. Patients who do not show bacteriuria at registration. Patients who have never taken medicine for CPPS or did not take same medicine more than 3 month until registration. Patients who can response for questionnaire and examination.
Exclusion criteria
Exclusion criteria: Patients who have acute bacterial prostatitis. Patients who have severe risk for urinary retention. Patients who show abnormal PSA or abnormality of urine cytology. Patients who have pneumonitis. Patients who have moderate ~ severe liver dysfunction. Patients who have aldosteronism. Patients who show low serum potassium. Patients who have myopathy. Patients who are judged as unfitness by physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate improvement of symptom at 12 weeks with estimated symptom score (NIH-CPSI, CESI & ICSI/ICPI). | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate improvement of symptom at 2 weeks with estimated symptom score, NIHCPSI, CESI & ICSI/ICPI. Evaluate improvement of urine flow rate & residual urine at 12 weeks. Evaluate safety and sustainability of Ryutanshakanto. | — |
Countries
Japan
Contacts
Public ContactKeiichi Kondo
Yokohama City University Hospital Dept. of Urology
Outcome results
None listed